LIONEX is actively participating and/or coordinating a number of research projects funded by the European Union, The WHO, FIND, German Federal Ministry for Research and Education (BMBF), German Federal Ministry of Commerce (BMWi). Research fields include diagnostics, vaccine and drug development, bladder cancer biomarkers and bladder cancer therapeutics. LIONEX is a leading manufacturer of highly purified, endotoxin free, mycobacterial antigens for research on tuberculosis and other mycobacterial diseases.
LIONEX is the licensed, exclusive manufacturer and distributor of a widely known family of endotoxin removal resin under the brand name EndoTrap®. EndoGrade®Ovalbumin is another useful product for research on vaccine development.
LIONEX cooperates with large research institutions, big pharma and large, international diagnostic companies from countries across the globe.
Only a limited list of partners is mentioned here.
NPO: NanoChimSyntez, Russia
Azienda Ospedaliero Universitaria
Policlinico Paolo Giaccone Palermo
UNIVERSITA DEGLI STUDI DI FIRENZE
Universita degli Studi di Roma
Central Laboratory of Advanced Diagnosis and Biomedical Research(CLADIBIOR),
University of Palermo
Universidade De Vigo
Kings College, London
St George’s, University of London
Department for Environment Food & Rural Affairs
Stellenbosh Univesity, S. Africa
If you have any question please contact us
© 2018 Lionex GmbH
Last update:Lionex GmbH